Alan Escher

Dr. Alan Escher, PhD, is Executive Vice President of Technology Development at SEKRIS Biomedical, Inc. (Redlands, California), a biotechnology company that develops innovative DNA immunotherapies for the treatment of inflammatory disorders like type 1 diabetes and organ transplant rejection. Dr. Escher was previously Associate Professor and Associate Director of the Center for Transplant Immunology Research at the Loma Linda University School of Medicine in Loma Linda, California. His training includes a PhD in Microbiology from Cornell University and a post-doctoral fellowship at the University of Alberta.

1books edited

2chapters authored

Latest work with IntechOpen by Alan Escher

This book contains a series of up-to-date chapters that review our current knowledge of type 1 diabetes as an autoimmune disease, the problems that still remain with existing treatments, and possible solutions for the near future.

Go to the book